Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 7:20 PM ET

Biotechnology

Company Overview of Spectrum Pharmaceuticals, Inc.

Executive Profile

Bimal R. Shah

Vice President of Finance - Business Development, Spectrum Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

----

Background

Mr. Bimal R. Shah serves as Vice President of Finance - Business Development at Spectrum Pharmaceuticals, Inc. Mr. Shah serves as the Chief Financial Officer and Treasurer at Allos Therapeutics, Inc. Mr. Shah was an Associate at Warburg Pincus LLC. He worked at New York office and was a Member of Healthcare and Biotechnology Group. Prior to joining Warburg Pincus in 2005, Mr. Shah was employed in the healthcare investment-banking group at Goldman, Sachs & Co., where ...

Corporate Headquarters

11500 South Eastern Avenue
Henderson, Nevada 89052

United States

Phone: 702-835-6300
Fax: 702-260-7405

Board Members Memberships

There is no Board Members Memberships data available.

Education

MA
Stanford University
BA
Stanford University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harry F. Hixson Jr., Ph.D.Chief Executive Officer, Independent Director, Chairman of Science Committee and Member of Corporate Governance and Nominating Committee
Arena Pharmaceuticals, Inc.
--
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$558.3K
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$551.7K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Andrew Philip Witty Chief Executive Officer, Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline S.A.E
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Spectrum Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.